论文部分内容阅读
本文报道血管紧张素转化酶抑制剂在缓解期慢性肺心病治疗中的应用效果。临床资料 1.治疗对象:明确诊断的慢性肺心病病人43例,均为经系统抗感染、氧疗、平喘、强心、利尿、扩血管等治疗后,咳、氮、喘等症状缓解,但仍有轻、中度浮肿者。其中男25例,女18例;年龄56-71岁。 2.治疗方法:将43例病人随机分为两组:治疗组22例,服复方卡托普利(卡托普利和双氢克尿噻)1-2片,每日3次,疗程至少2周以上;对照组2例,服双氢克尿噻12.5毫克～25毫克,每日3次,间断或持续应用2周以上。
This article reports the application of angiotensin converting enzyme inhibitors in the treatment of chronic pulmonary heart disease in remission. Clinical data 1. Subjects: Forty-three patients with definite diagnosis of chronic pulmonary heart disease were relieved of symptoms such as cough, nitrogen and asthma after systemic anti-infective, oxygen therapy, antiasthmatic, cardiac, diuretic and vasodilator therapy, But there are still mild to moderate edema. Including 25 males and 18 females; aged 56-71 years old. 2. Treatment: 43 patients were randomly divided into two groups: the treatment group of 22 cases, serving captopril (Captopril and hydrochlorothiazide) 1-2 tablets three times daily for at least 2 Week or more; control group, 2 cases, taking hydrochlorothiazide 12.5 mg ~ 25 mg three times a day, intermittent or continuous application of more than two weeks.